Results 31 to 40 of about 2,218 (168)

A Practical Guide to Genetic Eye Conditions for Paediatricians

open access: yesJournal of Paediatrics and Child Health, Volume 61, Issue 10, Page 1538-1548, October 2025.
ABSTRACT Introduction Inherited eye disorders, though individually rare, are a collectively common cause of paediatric vision impairment. Many occur as part of a syndrome, in association with congenital anomalies and/or growth/developmental disorders.
Richard Lin   +5 more
wiley   +1 more source

Longitudinal Visual Biomarkers in Dominant Optic Atrophy: A Systematic Review and Meta‐Analysis

open access: yesClinical &Experimental Ophthalmology, Volume 53, Issue 6, Page 652-659, August 2025.
ABSTRACT Background Dominant Optic Atrophy (DOA) causes slowly progressive visual decline usually beginning in childhood. As new therapies come to clinical trial, the choice of biomarkers to be used as clinical trial endpoints has become a critical question to be addressed. Methods We undertook a systematic review and meta‐analysis of studies reporting
Christopher A. Ovens   +2 more
wiley   +1 more source

Correlation of Structure With Function: Future Utilities for Optical Coherence Tomography Angiography in Neuro‐Ophthalmology

open access: yesClinical &Experimental Ophthalmology, Volume 53, Issue 6, Page 682-697, August 2025.
ABSTRACT Optical coherence tomography angiography is a burgeoning imaging modality in Ophthalmology. In this review, we outline the breadth of potential utility for optical coherence tomography angiography for diagnosis and prognostication in neuro‐ophthalmology.
Marzieh Tahmasebi Sarvestani   +2 more
wiley   +1 more source

Evaluating Color Deficiencies in Patients With Optic Neuropathies

open access: yes, 2022
Among the key hallmarks of optic neuropathies is dyschromatopsia[1]. Quantitating dyschromatopsia is important as a study endpoint; however, common color vision testing methods have limitations or confounding variables[2].
Lauren Ciulla; David Gu; Neena Cherayil; Nicholas Volpe; Shira Simon
core  

Pharmacovigilance on Dexamethasone 1 mg/mL + Levofloxacin 5 mg/mL Eye Drops, Solution: A Five‐Year Registry

open access: yesClinical and Translational Science, Volume 18, Issue 7, July 2025.
Since its authorisation in 2020, Dexamethasone 1 mg/mL + Levofloxacin 5 mg/mL Eye Drops, Solution has been administered to approximately 4 million patients worldwide for prevention and treatment of inflammation and prevention of infection associated with cataract surgery in adults.
Giorgio Ciprandi   +5 more
wiley   +1 more source

Portuguese Society of Ophthalmology and Portuguese Society of Human Genetics Joint Clinical Practice Guidelines for Genetic Testing in Inherited Retinal Dystrophies

open access: yesClinical Genetics, Volume 107, Issue 6, Page 600-611, June 2025.
This study provides clinical practice guidelines to streamline genetic testing for inherited retinal dystrophies (IRDs), underscoring the critical role of molecular diagnosis in enhancing patient care. These recommendations aim to elevate diagnostic accuracy, guide therapeutic decisions, and ultimately improve patient outcomes, marking a significant ...
João Pedro Marques   +6 more
wiley   +1 more source

Advancements in multiple sclerosis

open access: yesInternal Medicine Journal, Volume 55, Issue 6, Page 895-904, June 2025.
Abstract The global prevalence of multiple sclerosis (MS) is increasing, and early diagnosis and treatment is essential in mitigating disability. While recent therapeutic advancements have significantly reduced relapse rates, the progressive and degenerative aspects of MS continue to pose major challenges.
Turlough Montague   +3 more
wiley   +1 more source

CB1 Receptor Antagonist Selonabant (ANEB‐001) Blocks Acute THC Effects in Healthy Volunteers: A Phase II Randomized Controlled Trial

open access: yesClinical Pharmacology &Therapeutics, Volume 117, Issue 5, Page 1427-1436, May 2025.
Emergency department visits due to cannabinoid‐induced toxicity, including acute cannabinoid intoxication (ACI) have increased worldwide as more states have liberalized cannabis policy. ACI symptoms include anxiety, panic attacks, tachycardia, and psychosis, primarily mediated through cannabinoid type 1 receptor (CB1) agonism by Δ9‐tetrahydrocannabinol
Andriy A. Gorbenko   +9 more
wiley   +1 more source

Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network [PDF]

open access: yes
Objective: The first international consensus criteria for optic neuritis (ICON) were published in 2022. We applied these criteria to a prospective, global observational study of acute optic neuritis (ON).
Russell C. Dale   +101 more
core   +4 more sources

Transient Dyschromatopsia, Static Form Agnosia, and Prosopagnosia Observed in a Patient with Anti-NMDA Receptor Encephalitis

open access: yes, 2019
We presented a case of a 19-year-old woman who suffered from anti-N-methyl-D-aspartate (NMDA) receptor encephalitis associated with ovarian teratoma.
Ritsuo Hashimoto   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy